Absorption, distribution, metabolism, and excretion of [14C]sesamin in rats

被引:33
|
作者
Tomimori, Namino [1 ]
Rogi, Tomohiro [1 ]
Shibata, Hiroshi [1 ]
机构
[1] Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto, Japan
关键词
Distribution; Excretion; Metabolites profile; Pharmacokinetics; Sesamin; HUMAN LIVER; CARDIOVASCULAR HYPERTROPHY; ANTIOXIDATIVE METABOLITES; NITRIC-OXIDE; SESAME SEED; IN-VIVO; ALCOHOL; LIGNANS; HUMANS; CYTOCHROME-P450;
D O I
10.1002/mnfr.201600844
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Scope: Sesamin is a major lignan in sesame seeds and has various physiological effects. Although metabolism of sesamin by cytochrome P450 or intestinal microflora has been reported, little is known concerning the mass balance, pharmacokinetics, and tissue distribution of sesamin. Methods and results: Absorption, distribution, metabolism, and excretion of [C-14] sesamin were investigated after a single oral dose of 5mg/kg in rats. Sesamin was absorbed with peak plasma radioactivity at 1.0 h and declined with a terminal half-life 4.7 h. The cumulative excretion of radioactivity was 37.5 +/- 3.1% in urine and 58.7 +/- 4.8% in feces. In bile duct-cannulated rats, the cumulative excretion of radioactivity was 66.3 +/- 8.4% in bile and 27.8 +/- 10.2% in urine. Tissue distribution was investigated using quantitative whole-body autoradiography. Radioactivity was widely distributed over the whole body and was highly detected in the liver and kidney. The metabolites profile was examined using radiochromatography. Sesamin was mainly distributed in the form of conjugate metabolites. Conclusions: Sesamin was absorbed efficiently and distributed over the whole body. In particular, sesamin was highly distributed in the form of the metabolites in the liver and kidney. The results of this study are useful in elucidating the action mechanism of sesamin.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Pharmacokinetics, absorption, metabolism, and excretion of [14C]ivosidenib (AG-120) in healthy male subjects
    Chandra Prakash
    Bin Fan
    Syed Altaf
    Sam Agresta
    Hua Liu
    Hua Yang
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 837 - 848
  • [32] Assessment of the absorption, metabolism and excretion of [14C]pasireotide in healthy volunteers using accelerator mass spectrometry
    T.-H. Lin
    K. Hu
    J. Flarakos
    M. Sharr-McMahon
    J. B. Mangold
    H. He
    Y. Wang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 181 - 188
  • [33] Pharmacokinetics, absorption, metabolism, and excretion of [14C]ivosidenib (AG-120) in healthy male subjects
    Prakash, Chandra
    Fan, Bin
    Altaf, Syed
    Agresta, Sam
    Liu, Hua
    Yang, Hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 837 - 848
  • [34] Absorption, distribution, metabolism and excretion of gemigliptin, a novel dipeptidyl peptidase IV inhibitor, in rats
    Kim, Yoon
    Kim, Unyong
    Kim, In Sook
    Lee, Sung-Hack
    Lee, Jaeick
    Kim, Dong-Hyun
    Yoo, Hye Hyun
    XENOBIOTICA, 2014, 44 (07) : 627 - 634
  • [35] The Absorption, Distribution, Metabolism, and Excretion of Binimetinib Following a Single Oral Dose of [14C]Binimetinib 45 mg in Healthy Male Participants
    Huynh, Dustin
    Hahn, Erik
    Reddy, Micaela B.
    Chavira, Renae
    Wollenberg, Lance
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2025, 13 (01):
  • [36] Absorption, Disposition, Metabolism, and Excretion of [3-14C]Caffeic Acid in Rats
    Omar, Maizatul H.
    Mullen, William
    Stalmach, Angelique
    Auger, Cyril
    Rouanet, Jean-Max
    Teissedre, Pierre-Louis
    Caldwell, Stuart T.
    Hartley, Richard C.
    Crozier, Alan
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (20) : 5205 - 5214
  • [37] Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
    Johnson, Theodore R.
    Tan, Weiwei
    Goulet, Lance
    Smith, Evan B.
    Yamazaki, Shinji
    Walker, Gregory S.
    O'Gorman, Melissa T.
    Bedarida, Gabriella
    Zou, Helen Y.
    Christensen, James G.
    Nguyen, Leslie N.
    Shen, Zhongzhou
    Dalvie, Deepak
    Bello, Akintunde
    Smith, Bill J.
    XENOBIOTICA, 2015, 45 (01) : 45 - 59
  • [38] Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
    Fuell, Yvonne
    Wallasch, Christian
    Hilton, Ashley
    Planz, Oliver
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans
    Karanam, Bindhu
    Addy, Carol
    Bateman, Thomas
    Reddy, Vijay Bhasker
    Li, Susie
    Dean, Dennis
    Li, Hankun
    Jones, Allen
    Schenk, David
    Zhang, Andy Shiqiang
    Braun, Matt
    Freeman, Amanda
    Flach, Stephen
    Stoch, Aubrey
    Chodakewitz, Jeff
    Wagner, John A.
    Kumar, Sanjeev
    XENOBIOTICA, 2010, 40 (10) : 691 - 700
  • [40] Metabolism, Excretion, and Mass Balance of [14C]-Rezafungin in Animals and Humans
    Ong, Voon
    Wills, Sarah
    Watson, Deborah
    Sandison, Taylor
    Flanagan, Shawn
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)